About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | A Study of NeoRecormon in Patients With Chronic Kidney Disease.

A Study of NeoRecormon in Patients With Chronic Kidney Disease.

NCT00437723·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Hoffmann-La Roche

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

adult patients,18-75 years of age;
end-stage renal disease, not on dialysis;
Hb \<110g/L.

You may not be if

unstable hypertension;
acute infections;
use of i.v. NeoRecormon, or use of any other ESA beside NeoRecormon;
myocardial infarction, unstable angina or venous thrombosis within 6 months before start of treatment.

The record

StatusCompleted

PhasePhase 4

Taking part90

Started—

UpdatedMay 14, 2009

Conditions

Where2

Belgrade, Serbia
Novi Sad, Serbia